CEVA INC
For the period ended Dec 31, 2025. Filed Feb 27, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 27, 2026
CEVA$24.45-1.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
| Year ended December 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| Cash flows from operating activities: | |||
| Net loss | $(11,878) | $(8,786) | $(10,638) |
| Adjustments required to reconcile net loss to net cash provided by (used in) operating activities: | |||
| Depreciation | 2,887 | 3,046 | 3,436 |
| Amortization of intangible assets | 1,996 | 1,090 | 833 |
| Equity-based compensation | 16,198 | 15,575 | 19,796 |
| Realized gain, net on sale of available-for-sale marketable securities | (90) | (14) | (56) |
| Amortization of discounts on available-for-sale marketable securities | (124) | (922) | (755) |
| Unrealized foreign exchange (gain) loss, net | (560) | 1,108 | (1,029) |
| Gain on sale of Intrinsix | (11,557) | — | — |
| Remeasurement of marketable equity securities | 2 | 94 | 257 |
| Changes in operating assets and liabilities: | |||
| Trade receivables, net | (25) | (6,777) | (11,846) |
| Prepaid expenses and other assets | (4,850) | (4,751) | 281 |
| Operating lease right-of-use assets | 3,305 | 1,167 | (11,675) |
| Accrued interest on bank deposits | (237) | 527 | (23) |
| Deferred taxes, net | 6,684 | (68) | 1,055 |
| Trade payables | (818) | (261) | 552 |
| Deferred revenues | (27) | 581 | (103) |
| Accrued expenses and other payables | (182) | 477 | (890) |
| Accrued payroll and related benefits | (3,737) | 2,664 | (1,987) |
| Operating lease liability | (3,273) | (810) | 10,226 |
| Income taxes payable | 67 | (221) | (706) |
| Accrued severance pay, net | (112) | (248) | (84) |
| Net cash provided by (used in) operating activities | (6,331) | 3,471 | (3,356) |
| Cash flows from investing activities: | |||
| Business combination | (3,600) | — | — |
| Asset acquisition | — | (753) | — |
| Purchase of property and equipment | (2,884) | (2,955) | (2,921) |
| Proceeds from the sale of Intrinsix, net | 30,589 | 540 | 3,470 |
| Investment in bank deposits | (2,000) | (2,000) | (2,705) |
| Proceeds from bank deposits | 6,000 | 10,000 | 2,000 |
| Investment in available-for-sale marketable securities | (40,026) | (46,864) | (106,440) |
| Proceeds from maturity of available-for-sale marketable securities | 10,340 | 29,780 | 61,297 |
| Proceeds from sale of available-for-sale marketable securities | 12,417 | 9,806 | 11,301 |
| Net cash provided by (used in) investing activities | 10,836 | (2,446) | (33,998) |
| Cash flows from financing activities: | |||
| Purchase of treasury stock | (6,163) | (8,456) | (7,150) |
| Proceeds from issuance of common stock, net of issuance costs | — | — | 63,261 |
| Proceeds from exercise of stock-based awards | 3,393 | 2,883 | 3,224 |
| Net cash provided by (used in) financing activities | (2,770) | (5,573) | 59,335 |
| Effect of exchange rate changes on cash and cash equivalents | 267 | (241) | 107 |
| Increase (decrease) in cash and cash equivalents | 2,002 | (4,789) | 22,088 |
| Cash and cash equivalents at the beginning of the year | 21,285 | 23,287 | 18,498 |
| Cash and cash equivalents at the end of the year | $23,287 | $18,498 | $40,586 |
| Year ended December 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| Supplemental information of cash-flows activities: | |||
| Cash paid during the year for: | |||
| Income and withholding taxes | $7,398 | $6,261 | $4,182 |
| Non-cash transactions: | |||
| Transaction costs related to the Intrinsix but unpaid at the end of the year | $25 | $— | $— |
| Property and equipment purchases incurred but unpaid at the end of the year | $— | $215 | $692 |
| Right-of-use assets obtained in the exchange for operating lease liabilities | $1,100 | $1,324 | $14,084 |
| Reconciliation of cash and cash equivalents as shown in the condensed consolidated statements of cash flow: | |||
| Cash and cash equivalents in the Consolidated Balance Sheets | $23,287 | $18,498 | $40,586 |
| Cash and cash equivalents included in assets of discontinued operation | — | — | — |
| Total cash and cash equivalents in the Consolidated Statements of Cash Flows | $23,287 | $18,498 | $40,586 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.